ABL Bio has ranked among the top searched stocks for 9 days in the past month.

As of 12:31 PM on the 19th, ABL Bio is trading at 35,200 KRW, up 0.57% from the previous day. This marks a 93.41% increase compared to May 27. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.

Today, foreigners have sold a net 93,000 shares of ABL Bio, while institutions have sold a net 12,000 shares, according to preliminary data. Over the past 5 days, individual investors have bought a net 144,844 shares, while foreigners and institutions have sold a net 87,643 shares and bought a net 12,816 shares, respectively.

On June 16, ABL Bio was a market topic with the headline "Benefiting from SK Biopharm’s IPO... Discussing technology transfers with 15 big pharma companies."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing